Mirati Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Mirati Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2022.
  • Mirati Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $620M, a 47.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $620M +$199M +47.2% Dec 31, 2022 10-K 2023-02-28
Q4 2021 $421M +$151M +55.7% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $270M +$111M +69.7% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $159M +$52.7M +49.4% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $107M +$26M +32.2% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $80.7M -$4.14M -4.88% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $84.8M +$28.5M +50.5% Dec 31, 2016 10-K 2018-03-08
Q4 2015 $56.4M +$22.4M +65.7% Dec 31, 2015 10-K 2017-03-09
Q4 2014 $34M +$12.3M +56.5% Dec 31, 2014 10-K 2016-03-09
Q4 2013 $21.7M +$8.34M +62.3% Dec 31, 2013 10-K 2015-03-11
Q4 2012 $13.4M Dec 31, 2012 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.